Reduced sox9 function promotes heart valve calcification phenotypes in vivo.

Area of Science:

• Cardiovascular Biology
• Molecular Genetics
• Connective Tissue Biology

Background:

• Heart valve calcification is a common disease with unknown causes, often requiring valve replacement.
• Sox9, a transcription factor, is crucial for cartilage development and is present in heart valves.
• The role of Sox9 deficiency in promoting heart valve calcification was previously unexamined.

Purpose of the Study:

• To investigate the function of Sox9 in maintaining mature heart valve connective tissue homeostasis.
• To determine if Sox9 deficiency contributes to heart valve calcification.

Main Methods:

• Utilized Sox9(fl/+);Col2a1-cre mice to study Sox9 function in vivo.
• Performed histological and molecular analyses on heart valve tissues.
• Investigated Sox9's role in vitro using direct knockdown and retinoic acid treatment.

Main Results:

• Sox9(fl/+);Col2a1-cre mice exhibited calcific lesions in heart valves with increased bone-related gene expression, inflammation, and matrix remodeling.
• Direct knockdown of Sox9 in vitro led to ectopic calcification in heart valves.
• Retinoic acid induced calcification in vitro, which was reduced by Sox9 overexpression.

Conclusions:

• Reduced Sox9 function promotes heart valve calcification.
• Sox9 deficiency is implicated as a potential genetic factor in calcific valvular disease.
• This study provides novel insights into the molecular mechanisms underlying heart valve calcification.